Diabetes - Latest PubMed facts...

New strategies to improve the intranasal absorption of insulin

ruslan.david@gmail.com (Administrator) — Sun, 14 Nov 2010 13:16:10 +0000

It seems that bioadhesive delivery systems or water-insoluble powders with absorption enhancers are the most promising methods for intranasal delivery of insulin.

Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus

ruslan.david@gmail.com (Administrator) — Sun, 14 Nov 2010 13:11:18 +0000

The present study demonstrated the long-term beneficial effect of metformin in non-obese (BMI < 25 kg/m2) diabetic patients.

Recent Applications of Peanut Phytoalexins

ruslan.david@gmail.com (Administrator) — Thu, 21 Oct 2010 21:40:53 +0000

In addition to their use as antioxidants and antimicrobials, peanut phytoalexins may possess beneficial health effects. Studies have shown these compounds to have anti-diabetic, anticancer, and vasodilatory effects.

A prospective study of dietary selenium intake and risk of type 2 diabetes

ruslan.david@gmail.com (Administrator) — Thu, 21 Oct 2010 21:34:58 +0000

These findings raise additional concerns about the association of selenium intake above the Recommended Dietary Allowance (55 mug/day) with diabetes risk.

Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice

ruslan.david@gmail.com (Administrator) — Tue, 27 Jul 2010 22:43:35 +0000

These findings imply that the waist circumference is an important additional piece of information for assessing the risk of type 2 DM, particularly among persons of low or normal weight.

Vitamin D levels and mortality in type 2 diabetes

ruslan.david@gmail.com (Administrator) — Fri, 16 Jul 2010 20:26:47 +0000

In type 2 diabetic patients, severe vitamin D deficiency predicts increased risk of all-cause and cardiovascular mortality, independent of urinary albumin excretion rate (UAER) and conventional cardiovascular risk factors. Whether vitamin D substitution improves prognosis remains to be investigated.

Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen

ruslan.david@gmail.com (Administrator) — Fri, 16 Jul 2010 20:04:06 +0000

Insulin pump therapy using a simple dosing regimen significantly improved glycemic control in patients with type 2 diabetes.

Efficacy of combined use of miglitol in Type 2 diabetes patients receiving insulin therapy-placebo-controlled double-blind comparative study

ruslan.david@gmail.com (Administrator) — Fri, 16 Jul 2010 19:48:40 +0000

Combined use of insulin and miglitol is useful for postprandial glucose regulation and improves glycemic control.

Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the juvenile diabetes research foundation continuous glucose monitoring randomized trial

ruslan.david@gmail.com (Administrator) — Tue, 06 Jul 2010 23:13:33 +0000

Individuals who use continuous glucose monitoring (CGM) on a near-daily basis can have substantial improvement in glycemic control.

One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice

ruslan.david@gmail.com (Administrator) — Tue, 06 Jul 2010 17:49:29 +0000

Exenatide leads to long-term improvement of glycaemic control as well as weight loss in a majority of patients not responding to combined oral drug therapy in real-world clinical practice.

The impact of diabetes education on blood glucose self-monitoring among older adults

ruslan.david@gmail.com (Administrator) — Thu, 24 Jun 2010 15:15:57 +0000

These findings support the effectiveness of self-management education programmes to increase self-care behaviours.

Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus

ruslan.david@gmail.com (Administrator) — Thu, 24 Jun 2010 15:07:25 +0000

These results demonstrate that exenatide acutely and profoundly inhibits postprandial excursions of proatherogenic lipids and lipoproteins and may offer additional cardiovascular risk reduction.

Incidence and development of diabetic microangiopathy of fulminant type 1 diabetes -comparison with non-fulminant type 1 diabetes

ruslan.david@gmail.com (Administrator) — Thu, 24 Jun 2010 14:57:52 +0000

No difference between the patients visiting the center with fulminant type 1 diabetes and those with non-fulminant type 1 diabetes was observed in the development of microangiopathy complications.

What do Youth with Type 1 Diabetes Know about the HbA1c Test?

ruslan.david@gmail.com (Administrator) — Thu, 24 Jun 2010 09:46:07 +0000

In this sample of mostly lower-income, minority youths with type 1 diabetes, there was a significant lack of knowledge concerning the meaning and implications of the HbA1c test.

Using dynamic pupillometry as a simple screening tool to detect autonomic neuropathy in patients with diabetes: a pilot study

ruslan.david@gmail.com (Administrator) — Thu, 24 Jun 2010 09:36:13 +0000

Dynamic pupillometry provides a simple, inexpensive, and noninvasive tool to screen high-risk diabetic patients for diabetic autonomic neuropathy.

Newly diagnosed diabetes mellitus as a risk factor for serious liver disease

ruslan.david@gmail.com (Administrator) — Thu, 24 Jun 2010 09:25:36 +0000

Adults with newly diagnosed diabetes appeared to be at higher risk of advanced liver disease, also known as diabetic hepatopathy.

Health economics and compliance of vials/syringes versus pen devices: a review of the evidence

ruslan.david@gmail.com (Administrator) — Fri, 11 Jun 2010 12:55:11 +0000

The use of pen devices improves the health economics benefits and adherence to insulin therapy.

Insulin pump use in Europe

ruslan.david@gmail.com (Administrator) — Fri, 11 Jun 2010 12:49:25 +0000

Although European groups have initiated innovative clinical research in the field of insulin pump therapy, insulin pump use remains currently limited in many European countries, and well behind that in the United States.

Evaluating older patients with diabetes for insulin pump therapy

ruslan.david@gmail.com (Administrator) — Fri, 11 Jun 2010 12:40:41 +0000

Successful implementation of insulin pump therapy for older patients requires an experienced diabetes management team that can assess patient needs and tailor therapy in the context of age-related disabilities.

Effects of aerobic exercise on abdominal fat, thigh muscle mass and muscle strength in type 2 diabetic subject

ruslan.david@gmail.com (Administrator) — Fri, 11 Jun 2010 12:15:10 +0000

Daily moderate intensity aerobic exercise is effective at reducing abdominal fat mass, while high intensity exercise improves cardiopulmonary function.